125
Views
0
CrossRef citations to date
0
Altmetric
Reviews

An update on anti-allergic patents granted in China: 2009 – 2011

, PhD, , PhD & , MD PhD
Pages 715-734 | Published online: 16 Jun 2012

Bibliography

  • Warner JO, Kaliner MA, Crisci CD, Allergy practice worldwide. a report by the World Allergy Organization Specialty and Training Council. Int Arch Allergy Immunol 2006;139:166-74
  • Asthma, chronic respiratory diseases. quick asthma facts. Available from: http://www.who.int/respiratory/asthma/en/index.html
  • Lovasi GS, Quinn JW, Neckerman KM, Children living in areas with more street trees have lower prevalence of asthma. J Epidemiol Community Health 2008;62:647-9
  • Zhang S, Zeng X, Wei J, Analysis of patents on anti-allergic therapies issued in China from 1988 to 2008. Expert Opin Ther Pat 2010;20:727-37
  • Institute of Hygiene and Environmental Medicine. The Academy of Military Medical Sciences. Human genetic engineering antibody TRD 109 as well as preparation method and application thereof. CN200910070978
  • O'Connell C, Hensey M, Mongey AB, A series of patients on anti-TNF therapy referred to a multidisciplinary lung cancer service. Ir J Med Sci 2012; [Epub ahead of print]
  • PLA Military Academy of Medical Sciences, Institute of Basic Medical. IL-1ra-Fcepsilon fusion gene and its encoded protein in the treatment of allergic rhinitis. CN201110030837
  • Bensky D, Clavey S, Stoger E. Gamble Chinese herbal medicine: materia medica. Volume 3 Eastland Press; Seattle: 2004
  • Li XM. Complementary and alternative medicine in pediatric allergic disorders. Curr Opin Allergy Clin Immunol 2009;9:161-7
  • Wen MC, Wei CH, Hu ZQ, Efficacy and tolerability of anti-asthma herbal medicine intervention in adult patients with moderate-severe allergic asthma. J Allergy Clin Immunol 2005;116:517-24
  • Chan CK, Kuo ML, Shen JJ, Ding Chuan Tang, a Chinese herb decoction, could improve airway hyper-responsiveness in stabilized asthmatic children: a randomized, double-blind clinical trial. Pediatr Allergy Immunol 2006;17:316-22
  • Chang TT, Huang CC, Hsu CH. Clinical evaluation of the Chinese herbal medicine formula STA-1 in the treatment of allergic asthma. Phytother Res 2006;20:342-7
  • Tang Y. Traditional Chinese medicine for treating respiratory system diseases. CN200910311635
  • Hui ZM. Chinese medicinal preparation for treating allergic asthma. CN200910140753
  • Zhang ZJ. Medicament for treating pediatric respiratory tract infection and pulmonary infection. CN201010102623
  • Huashan Hospital Affiliated to Fudan University. A drug for prevention and treatment of allergic respiratory disease. CN201010155956
  • Huangnian Cetral Hospital of Changzhi Suburb. Medicine for treating allergic rhinitis. CN200910075467
  • Shanxi Province Acupuncture Research Institute. Medicament for treating children chronic cough and allergic rhinitis and preparation method thereof. CN200910227910
  • Cheng XL. A drug for treatment of allergic rhinitis. CN200910018002
  • Shanxi Institute of Acupuncture. A drug for treatment of chronic, intractable pulmonary system diseases and preparation method thereof. CN200910227911
  • Wang D. A Chinese traditional medicine for treating allergic rhinitis. CN200910229355
  • Ding CY. A Chinese traditional medicine for treating allergic rhinitis. CN200910230238
  • Zhang XB. A Chinese traditional medicine for treating allergic rhinitis. CN200910229713
  • Huang S. A granule for allergic rhinitis. CN200910170000
  • Huang Z. A Chinese traditional medicine for treating allergic rhinitis. CN200910096121
  • Xiao CG. A Chinese traditional medicine for treating children allergic rhinitis. CN200910015934
  • Fujian University of Traditional Chinese Medicine. Medicinal composition for treating allergic rhinitis and preparation method and application thereof. CN 201010238755
  • Zhu YW. A Chinese traditional medicine for treating allergic rhinitis and preparation method. CN201010589907
  • Li YS. Oral liquid, granule and powder for prevention and treatment of allergic rhinitis. CN201010540784
  • Affiliated Hospital of Medical College of Qiingdao University. A drug for treatment of allergic rhinitis and its preparing method. CN201010529298
  • Ge DJ. A drug for treatment of allergic rhinitis and its preparing method. CN201010264640
  • Liu H. A drug for treatment of allergic rhinitis and its preparing method. CN201010264284
  • Wang JH. A drug for treatment of allergic rhinitis and its preparing method. CN201010250125
  • Li F. Chinese medicament for treating allergic rhinitis and preparation process thereof. CN201010227695
  • Zhejiang Tailison Pharmaceutical Co., Ltd. Chinese medicament for treating allergic rhinitis and acute/chronic rhinitis, and preparation process thereof. CN201010209603
  • Wu CY. Acupoint transdermal patch for treating allergic rhinitis and preparation process thereof. CN201110117606
  • Xu HL. An oral Chinese medicine decoction for treatment of allergic rhinitis. CN201110142675
  • Jin JS. A drug for treatment of allergic rhinitis. CN201110239248
  • Guo ZP. A drug for treatment of allergic rhinitis and its preparing method. CN201110219757
  • Han BZ. A nasal drops for treatment of allergic rhinitis. CN201110240464
  • Zhou YQ. A drug for treatment of allergic rhinitis and its preparing method. CN201110219758
  • Shangdong Province-owned Hospital. Chinese medicament for treating allergic rhinitis. CN201110195263
  • Chen XC. Medicament for treating allergic rhinitis and preparation method thereof. CN201110030819
  • Shandong provincial Qianfo Hill hospital. Chinese medicament for treating allergic rhinitis. CN201110060739
  • Bao XG. A drug for treatment of allergic rhinitis and its preparing method. CN201110057874
  • Ji'nan Jinding Information Technology Co. Ltd. Chinese medicament for treating allergic rhinitis. CN201110133097
  • Sun BJ. A drug for treatment of allergic rhinitis. CN201110130526
  • Ding J. Chinese medicament for treating allergic rhinitis. CN201110167223
  • Nanjing Hecai Bio-Tech Co., Ltd. A desensitizing agent and its use. CN201110061435
  • Hon KL, Leung TF, Ng PC, Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double-blind, placebo-controlled study. Br J Dermatol 2007;157:357-63
  • Huo J. Medicament for treating and resisting allergic diseases. CN200910013268
  • Lanzhou Guchi Bio-Tech Co., Ltd. Medicament for treating allergic dermatitis and application thereof in producing skincare products. CN201010190838
  • The Fourth Military Medical University. Oral administration medicament for treating dermatitis. CN201110024698
  • Ding JX. Chinese medicament for treating allergic dermatitis. CN201110022924
  • Jiang LW. A umbilical plaster for treatment of allergic skin pruritus and ringworm and preparation method thereof. CN201110099117
  • Guo CF. Chinese medicinal formula for treating allergic purpura. CN200910230431
  • Yang WM. Medicine for treating anaphylactoid purpura and preparation method thereof. CN201010505907
  • Chen SL. Traditional Chinese medicine for treating thrombocytopenia and Henoch-Schonlein purpura. CN201010296873
  • Yang J. Traditional Chinese medicine for treating allergic purpura. CN200910182592
  • Jia GS. Chinese medicinal formula for treating anaphylactoid purpura and preparation method thereof. CN200910075890
  • Jilin Tianyao modern traditional Chinese medicine Bio-Tech Co., Ltd. Medicine for treating anaphylactoid purpura and preparation method thereof. CN200910066836
  • Liu F. Medicine for treating anaphylactoid purpura. CN200910018417
  • Jia SY. Ointment for treating anaphylactoid purpura. CN200910008264
  • Zhang YP. Chinese medicinal formula for treating anaphylactoid purpura. CN201010100869
  • Beijing Zhongkexuekang blood disease medical research institute. Chinese medicinal formula for treating anaphylactoid purpura and thrombocytopenic purpura. CN201110214688
  • Yue SL. Traditional Chinese medicine for treating Henoch-Schonlein purpura nephritis. CN201110043740
  • The Inner Mongolia Autonomous Region Mongolian hospital. Medicine for treating anaphylactoid purpura. CN201110201128
  • Liu YJ. Medicine for treating anaphylactoid purpura. CN201110143503
  • Baotou Chinese medicine Co., Ltd. Medicine for treating anaphylactoid purpura. CN201110119466
  • Shanghai Saifu chemical industry Co., Ltd. Anti-allergic natural plant extract and its preparation method and uses. CN201010146018
  • Nanjing Saint Bio-Tech Co., Ltd. Anti-allergic raspberry compound and its preparation method. CN201010570257
  • Jiang LW. Anti-allergic traditional Chinese medicine preparation and preparation method thereof. CN201010125588
  • Lim KT. Inhibitory effect of glycoprotein isolated from Opuntia ficus-indica var. saboten MAKINO on activities of allergy-mediators in compound 48/80-stimulated mast cells. Cell Immunol 2010;264:78-85
  • Oh HA, Kim HM, Jeong HJ. Alleviation of allergic rhinitis symptoms with Pyeongwee-San extracts (KMP6). Immunopharmacol Immunotoxicol 2012;34:149-56
  • Kim D, Kim SH, Park EJ, Suppression of allergic diarrhea in murine ovalbumin-induced allergic diarrhea model by PG102, a water-soluble extract prepared from Actinidia arguta. Int Arch Allergy Immunol 2009;150:164-71
  • Pierre Fabre skin cosmetics Co. Hypoallergenic dermatological composition. CN200980145257, (WO2009061971)
  • Nanjing Zelang of Agriculture Development Co., Ltd. Arctigenin in the preparation of the treatment of allergic asthma medication. CN201110117906
  • Weiss R, Hammerl P, Hartl A, Design of protective and therapeutic DNA vaccines for the treatment of allergic diseases. Curr Drug Targets Inflamm Allergy 2005;4:585-97
  • Prescott SL, Jones CA. An update of immunotherapy for specific allergies. Curr Drug Targets Inflamm Allergy 2002;1:65-75
  • Focke M, Swoboda I, Marth K, Valenta R. Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity. Clin Exp Allergy 2010;40:385-97
  • Campbell JD, Buckland KF, McMillan SJ, Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression. J Exp Med 2009;206:1535-47
  • Bial Ind Farmaceutica S. A. Hypoallergenic hybrid proteins of major group 1 and 2 mite allergens for use in the treatment of allergies. CN200980110215, (WO2009005114)
  • Circassia Ltd. Vaccine comprising Amb a 1 peptides for use in the treatment of ragweed allergy. CN200980139316, (WO2009001986)
  • Fudan University. A recombinant main branch Neurospora crassa allergen Cla h8 protein preparation method and its use. CN201010141209
  • The First Affiliated Hospital of Nanjing Medical University. Method for producing blattella germanica allergen BgGSTD1 protein in bacilliform virus-insect expression system. CN200910024994
  • The First Affiliated Hospital of Nanjing Medical University. Method for producing Americana linn allergen protein Per a 5 in bacilliform virus-insect expression system. CN200910031901
  • The First Affiliated Hospital of Nanjing Medical University. Method for producing Americana linn allergen protein Per a 9 in bacilliform virus-insect expression system. CN200910031902
  • Alker-Abello Co., Ltd. Pharmaceutical product for up-dosing of allergy vaccine. CN200980140840, (WO2009063489)
  • Owen CE. Immunoglobulin E: role in asthma and allergic disease: lessons from the clinic. Pharmacol Ther 2007;113:121-33
  • Chang TW. The pharmacological basis of anti-IgE therapy. Nat Biotechnol 2000;18:157-62
  • Barrios JL, Paradis L, Desroches A. Efficacy of Omalizumab therapy in a case of severe atopic dermatitis. Allergy Asthma Clin Immunol 2011;7(Suppl 2):A33
  • Vichyanond P. Omalizumab in allergic diseases, a recent review. Asian Pac J Allergy Immunol 2011;29:209-19
  • Qian WZ, Zhang XM, Li BH. Development and characterization of a novel anti-IgE monoclonal antibody. Biochem Biophys Res Commun 2010;395:547-52
  • Laffer S, Lupinek C, Rauter I, A high-affinity monoclonal anti-IgE antibody for depletion of IgE and IgE-bearing cells. Allergy 2008;63:695-702
  • Fudan University. Humanized monoclonal antibody IgG Fab fragment of dermatophagoides farinae 2 allergoid specificity as well as preparation method and application thereof. CN200910051875
  • BaiMaibo Pharmaceutical Co., Ltd. A human anti-IgE monoclonal antibody, its preparation and use. CN201010125245
  • Kingston DGI, Newman DJ. Natural products as drug leads: an old process or the new hope for drug discovery? IDrugs 2005;8:990-2
  • Nagai H, Teramachi H, Yuchiya T. Recent Advances in the Development of Anti-allergic Drugs. Allergol Int 2006;55:35-42
  • Murray JJ, Tonnel AB, Brash AR, Release of prostaglandin D2 into human airways during acute antigen challenge. N Engl J Med 1986;315:800-4
  • Luna-Gomes T, Magalhaes KG, Mesquita-Santos FP, Eosinophils as a Novel Cell Source of Prostaglandin D2: autocrine Role in Allergic Inflammation. J Immunol 2011;187:6518-26
  • Hirai H, Tanaka K, Yoshie O, Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med 2001;193:255-61
  • Oxagen Ltd. Compounds having crth2 antagonist activity. CN200980103456, (WO2009000142)
  • Taisho Pharmaceutical Co., Ltd. Isoquinoline derivatives. CN200980152382, (WO2009071633)
  • Guizhou Finder Pharmaceutical Co., Ltd. A pharmaceutical formulation for treating skin sensibility. CN200910301935
  • Zhao MZ. Internal medicine combined with Chinese and western medicine for curing allergic rhinitis and preparation method thereof. CN200910113208
  • Huaxipharm Co., Ltd. Leukotriene antagonist and anti-histaminics composition. CN201010033999
  • Geng FN. Pharmaceutical composition for treating allergic rhinitis and preparation method thereof. CN201010182489
  • Guo WJ. An electric heating type tile ceramic fumigant canister to prevent and control allergic rhinitis. CN201120026852
  • Bochner BS, Schleimer RP. Mast cells, basophils, and eosinophils: distinct but overlapping pathways for recruitment. Immunol Rev 2001;179:5-15
  • Bochner BS. Leukocyte recruitment in allergic pulmonary inflammation. In: Eissa T, Huston D, editors. Therapeutic targets of airway inflammation. Marcel Dekker, Inc; New York, 2003. p. 223-47
  • Bochner BS. Verdict in the case of therapies versus eosinophils: the jury is still out. J Allergy Clin Immunol 2004;113:3-9
  • Robinson DS, Hamid Q, Ying S, Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304
  • Akdis CA, Akdis M, Simon D, T cells and T cell-derived cytokines as pathogenic factors in the nonallergic form of atopic dermatitis. J Invest Dermatol 1999;113:628-34
  • Gratzl S, Palca A, Schmitz M, Simon HU. Treatment with IFN- corticosteroid-unresponsive asthma. J Allergy Clin Immunol 2000;105:1035-6
  • Northeast Agricultural University. Preparation of whole peptidoglycan of Lactobacillus species with anti-allergic effects of beta-lactoglobulin, products and applications. CN201110236429
  • Borish LC, Nelson HS, Corren J, Efficacy of soluble IL-4 receptor for the treatment of adults with asthma. J Allergy Clin Immunol 2001;107:963-70
  • Leckie MJ, ten Brinke A, Khan J, Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000;356:2144-8
  • WYETH LLC. Methods of treatment utilizing binding proteins of the interleukin-21 receptor. CN200980128941, (WO2009045188)
  • Kaplan AP. Chemokines, chemokine receptors and allergy. Int Arch Allergy Immunol 2001;124:423-31
  • Topigen Pharmaceuticals, Inc. Oligonucleotides for treating inflammation and neoplastic cell proliferation. CN200980127557, (WO2009000415)
  • Bristol-Myers Squibb Co. Piperidinyl derivative as modulator of chemokine receptor activity. CN200980124564, (WO2009048564)
  • Bristol-Myers Squibb Co. Hydroxyalkanyl amides as modulators of chemokine receptor activity. CN200980116485, (WO2009036120)
  • Bristol-Myers Squibb Co. Cyclohexenyl modulators of chemokine receptor activity. CN200980136193, (WO2009050449)
  • Bristol-Myers Squibb Co. Chromene modulators of chemokine receptor activity. CN200980136197, (WO2009050450)
  • Furuichi K, Katakura Y, Ninomiya K, Shioya S. Enhancement of 1,4-dihydroxy-2-naphthoic acid production by Propionibacterium freudenreichii ET-3 fed-batch culture. Appl Environ Microbiol 2007;73:3137-43
  • Meiji Dairies Corp. Anti-allergic agent. CN200980106607, (WO2009000851)
  • Synbio Tech, Inc. Lactobacillus planetarium strain LP28 and application thereof in mitigation of anaphylactic reaction. CN200910258587
  • Liaoning University. Application of pectin polysaccharide in preparation of anti-allergic food, medicine or cosmetic. CN200910013139
  • Marinomed Biotechnologie GmbH. Anti-allergic marine biopolymers. CN200980122094, (WO2009004696)
  • Xinjiang Uygur Autonomous Region Research Institute of Chinese Medicine & National Medicine. Method for extracting medicament for treating allergic colitis from Alhagi sparsifolia plant and medicament and application. CN201010205712
  • Wu Sophia Shu Fen. Polysaccharides extract from dendrobium for treating allergic diseases. CN200980128681, (WO2009051084)
  • Chen SZ, Preparation of the Magnolia biondii Pamp. oil soft capsule to treatment of allergic rhinitis and related diseases. CN201110174804
  • Nanjing University of Chinese Medicine. Application of ginseng alkynol in pharmacy. CN200910029315
  • Sichuan Academy of Pharmaceutical Sciences. The drugs For autoimmune allergic diseases. CN201110101704
  • Nanjing University of Chinese Medicine. Application of astragaloside in treating delayed type hypersensitivity mediated diseases. CN200910034883
  • Wang Q. The use of ginkgo phenolic acids in the preparation of dermopathic external application. CN201110236640; CN201110236703
  • Chengdu Baikang Pharmaceutical Industry Pharmacology and Toxicology Research Institute. New medical application of beta-sodium aescinate. CN200910263428
  • Shanghai Jiaotong University School of Medicine. Novel medicinal application of baicalein. CN200910200927
  • Li GY. A group of dopamine polymer and its derivatives and its preparation method and medicinal use. CN201110101168
  • Alk Abello AS. Allergy vaccine composition for mucosal administration. CN200980101639, (WO2009050137)
  • Alker-Abello Co., Ltd. Water-containing liquid allergic reaction bacterin preparation for mouth mucosa drug administration. CN200910130722
  • Curevac GmbH. Nucleic acids of formula (i) (NuGlXmGnNv) a and derivatives thereof as an immunostimulating agent/adjuvant. CN200980103728, (WO2009000546)
  • Heilongjiang Soybean Technology Research and Development Center. Method for preparing soy protein immune-active peptides and product thereof. CN200910150773
  • Heilongjiang Suokang Nutrition Technology Co., Ltd. Application of whey protein peptide in preparation of drugs and health food for enhancing immunity. CN200910177408
  • Argos Therapeutics, Inc. Novel soluble cd83 polypeptides, formulations and methods of use. CN200980118634, (WO2009003174)
  • Valtion Teknillinen. Modified beta-lactoglobulins for immunotherapy of milk allergy. CN200980131722, (WO2009050549)
  • Beijing Xinhualian Concorde Pharmaceutical Co., Ltd. Medicine for treating anaphylactic disease and preparation method thereof. CN200910076609
  • Zhejiang Wolwo Biotech Co., Ltd. Stable medicinal composition containing artemisia pollen allergen and preparation method thereof. CN200910147470
  • Beijing Hualian Concord Pharmaceutical Co., Ltd. A mite freeze-dried vaccine and its preparation method. CN201110199519
  • XENCOR Co. New compositions and methods for the treatment of IgE-mediated disorders. CN200980136559, (WO2009057366)
  • Shanghai Zhangjiang Bio-Technology Co., Ltd. A stable humanized monoclonal antibody preparations. CN201010225357
  • Kameda Seika Co. Ltd. Novel lactic acid bacterium having anti-allergic activity, anti-allergic agent, food and pharmaceutical composition each comprising the lactic acid bacterium, and process for production. CN200980114416, (WO2009058141)
  • Beijing Sai'er Taihe Biopharmaceutical Technology Co., Ltd. Injection for treating skin allergy and allergic asthma and preparation method thereof. CN201010574276
  • Beijing Sai'er Taihe Biopharmaceutical Technology Co., Ltd. An injection of treatment for spring allergies and allergic asthma and its preparation method. CN201110150490
  • Arena Pharm, Inc. Modulators of the histamine h3 receptor useful for the treatment of disorders related thereto. CN200980113759, (WO2009001022)
  • Array Biopharma, Inc. 7-phenoxychroman carboxylic acid derivatives. CN200980157228
  • Novartis AG. Pyridines and pyrazines as inhibitors of PI3K. CN200980117994, (WO2009053136)
  • Astellas Pharmaceutical Co., Ltd. Pyrimidine derivatives. CN201080007841
  • Kowa Co. Substituted carbinol compound having cyclic linker. CN200980128898, (WO2009002406)
  • Tianjin Pacific Pharmaceutical Co., Ltd. Anti-allergic medicament and application thereof. CN200910071174
  • Wenzhou medical college. 2,3-dehydrosilybin 23-ester, and preparation and pharmaceutical use thereof. CN200910096042
  • Nexgenix Pharmaceutical Co. Macrocyclic prodrug compounds useful as therapeutics. CN200980114040, (WO2009034878)
  • Taisho Pharmaceutical Co., Ltd. The dihydroquinoline ketone derivatives. CN201080006935
  • China Pharmaceutical University. Benzo [5,6] ring heptyl [1,2-b] pyridine derivatives, preparation methods, the pharmaceutical compositions and the use of anti-allergic diseases. CN201110153330
  • GlaxoSmithKline, Lic. Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases. CN200980141081, (WO2009060263)
  • GlaxoSmithKline, Lic. Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases. CN200980141103, (WO2009060265)
  • GlaxoSmithKline, Lic. Novel adenine derivatives. CN200980141082, (WO2009060267)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.